Nitracrine

Modify Date: 2024-01-10 13:39:37

Nitracrine Structure
Nitracrine structure
Common Name Nitracrine
CAS Number 4533-39-5 Molecular Weight 324.37700
Density 1.269g/cm3 Boiling Point 522ºC at 760mmHg
Molecular Formula C18H20N4O2 Melting Point N/A
MSDS N/A Flash Point 269.5ºC

 Use of Nitracrine


Nitracrine is an antitumor drug that has been used clinically for several years.

 Names

Name Nitracrine
Synonym More Synonyms

 Nitracrine Biological Activity

Description Nitracrine is an antitumor drug that has been used clinically for several years.
Related Catalog
In Vitro It is demonstrated during the reduction of ledakrin that a key metabolite, a compound with anadditional five-membered ring attaching to positions 1 and 9 of the acridine core and with the retained 9-aminoalkyl side chain, is formed in all the systems that are studied. It is determined that the reactive nitrogen atoms of this additional ring undergo further transformations resulting in the formation of a six-membered ring produced by the addition of a carbon atom to the dihydropyrazoloacridine ring. Furthermore, it is observed that positions 2 and 4 of ledakrin’s acridine ring are susceptible to nucleophilic substitution as revealing by the studies with dithiothreitol. Additionally, although most products from the reduction of ledakrin are extremely unstable, 1-aminoacridinone, producing enzymatically and with dithiothreitol, exhibiting persistent stability under the studied conditions[1].
Cell Assay Six-week-old male rats are injected with 3-methylcholanthrene (4 mg/animal) for 3 days before decapitation. Livers are removed, homogenized in a homogenizer, and centrifuged for 30 min at 10000g.The activation of ledakrin with the microsomal fraction of rat liver is carried out in 0.16 M Trizma base buffer (pH 7.4). The incubation mixture consists of 125 mM nicotinamide, 100 mM glucose 6-phosphate, 10 mM NADPH, glucose-6-phosphate dehydrogenase (40 units), rat liver microsomes (5 mg/mL), andledakrin (1 mmol)[1].
References

[1]. Gorlewska K, et al. Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro.

 Chemical & Physical Properties

Density 1.269g/cm3
Boiling Point 522ºC at 760mmHg
Molecular Formula C18H20N4O2
Molecular Weight 324.37700
Flash Point 269.5ºC
Exact Mass 324.15900
PSA 73.98000
LogP 4.25600
Index of Refraction 1.697
Storage condition 2-8℃

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AR9240000
CHEMICAL NAME :
Acridine, 9-(3-(dimethylamino)propylamino)-1-nitro-
CAS REGISTRY NUMBER :
4533-39-5
LAST UPDATED :
199604
DATA ITEMS CITED :
13
MOLECULAR FORMULA :
C18-H20-N4-O2
MOLECULAR WEIGHT :
324.42
WISWESSER LINE NOTATION :
T C666 BNJ GNW IM3N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
DNA adduct

MUTATION DATA

TYPE OF TEST :
Mutation in mammalian somatic cells
TEST SYSTEM :
Rodent - hamster Lung
DOSE/DURATION :
150 ug/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 204,655,1988

 Safety Information

HS Code 2933990090

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

1-nitro-9-(3-N,N-dimethylaminopropylamino)acridine
9-(3-dimethylaminopropylamino)-1-nitroacridine
N,N-dimethyl-N'-(1-nitro-9-acridyl)propane-1,3-diamine
3-(dimethylamino)propyl-(1-nitroacridin-9-yl)amine
N',N'-dimethyl-N-(1-nitroacridin-9-yl)propane-1,3-diamine